Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hexaxim versus Infanrix hexa with concomitant PCV13 in healthy infants
2012-001054-26Phase 3Completed
- Sponsor
- Sanofi
- Start
- Jun 2012
- Modality
- Vaccines & Immunotherapeutics, Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of hexaxim, pertussis filamentous haemagglutinin, pneumococcal 13-valent conjugate vaccine in vaccine-preventable bacterial and viral infections (VPD), diphtheria, Tetanus, pertussis, poliomyelitis, sponsored by Sanofi. Started Jun 2012; status: completed.
02
Drugs
hexaximpertussis filamentous haemagglutininpneumococcal 13-valent conjugate vaccine
03
Conditions
vaccine-preventable bacterial and viral infections (VPD)diphtheriaTetanuspertussispoliomyelitis
Beyond the preview
Go deeper on 2012-001054-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001054-26.